Search research articles
Contact Us
Filters
Showing results (31-40 of 188) with videos related to
Page
of 19
Sort By:
Clinical Chemistry and Laboratory Medicine
|
September 2, 2020
Determination of free light chains: assay-dependent differences in interpretation
Xavier Bossuyt, Koen Poesen, Ben Sprangers, et al.
Case Reports in Hematology
|
June 14, 2016
Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma
Jan Van Keer, Michel Delforge, Daan Dierickx, et al.
Acta Clinica Belgica
|
February 10, 2025
Suspect the unexpected: proliferative glomerulonephritis with monoclonal immunoglobulin deposits and a negative hematological work-up. A case of monoclonal gammopathy of renal significance
Benoît Delforge, Elien Mahieu, Amélie Dendooven, et al.
European Heart Journal. Case Reports
|
March 18, 2022
Case report: Two sisters with light-chain cardiac amyloidosis, a mere coincidence?
Sarah Cappuyns, Matthias Verbesselt, Alexander Van De Bruaene, et al.
Leukemia
|
August 31, 2019
Carfilzomib-induced reticulocytosis in patients with multiple myeloma is caused by impaired terminal erythroid maturation
Nicolas G Kint, Elien Heylen, Daniele Pepe, et al.
Annals of Hematology
|
August 6, 2017
Blinatumomab in relapsed/refractory diffuse large B cell lymphoma
Ruben Van Dijck, Ann Janssens, Daan Dierickx, et al.
Oncotargets and Therapy
|
March 21, 2022
Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma Patients
Michel Delforge, Jolien Raddoux, Corine Antonis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
September 26, 2009
Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders
Pieter Vermeersch, Martine Vercammen, Annelies Holvoet, et al.
Leukemia
|
April 21, 2018
Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used
Xavier Bossuyt, Michel Delforge, Martin Reynders, et al.
Clinical Chemistry and Laboratory Medicine
|
April 22, 2018
Antigen excess detection by automated assays for free light chains
Xavier Bossuyt, Michel Delforge, Martin Reynders, et al.
Page
of 19
Search research articles
Search
Showing results (31-40 of 188) with videos related to
Sort By:
Page
of 19
Clinical Chemistry and Laboratory Medicine
|
September 2, 2020
Determination of free light chains: assay-dependent differences in interpretation
Xavier Bossuyt, Koen Poesen, Ben Sprangers, et al.
Case Reports in Hematology
|
June 14, 2016
Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma
Jan Van Keer, Michel Delforge, Daan Dierickx, et al.
Acta Clinica Belgica
|
February 10, 2025
Suspect the unexpected: proliferative glomerulonephritis with monoclonal immunoglobulin deposits and a negative hematological work-up. A case of monoclonal gammopathy of renal significance
Benoît Delforge, Elien Mahieu, Amélie Dendooven, et al.
European Heart Journal. Case Reports
|
March 18, 2022
Case report: Two sisters with light-chain cardiac amyloidosis, a mere coincidence?
Sarah Cappuyns, Matthias Verbesselt, Alexander Van De Bruaene, et al.
Leukemia
|
August 31, 2019
Carfilzomib-induced reticulocytosis in patients with multiple myeloma is caused by impaired terminal erythroid maturation
Nicolas G Kint, Elien Heylen, Daniele Pepe, et al.
Annals of Hematology
|
August 6, 2017
Blinatumomab in relapsed/refractory diffuse large B cell lymphoma
Ruben Van Dijck, Ann Janssens, Daan Dierickx, et al.
Oncotargets and Therapy
|
March 21, 2022
Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma Patients
Michel Delforge, Jolien Raddoux, Corine Antonis, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
September 26, 2009
Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders
Pieter Vermeersch, Martine Vercammen, Annelies Holvoet, et al.
Leukemia
|
April 21, 2018
Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used
Xavier Bossuyt, Michel Delforge, Martin Reynders, et al.
Clinical Chemistry and Laboratory Medicine
|
April 22, 2018
Antigen excess detection by automated assays for free light chains
Xavier Bossuyt, Michel Delforge, Martin Reynders, et al.
Page
of 19